Skip to menu Skip to content Skip to footer
Associate Professor David Wyld
Associate Professor

David Wyld

Email: 

Overview

Availability

Associate Professor David Wyld is:
Available for supervision

Works

Search Professor David Wyld’s works on UQ eSpace

201 works between 1998 and 2025

121 - 140 of 201 works

2017

Conference Publication

Patient reported outcomes (PROs) in clinical practice: a scoping review of reviews, systematic review and meta-analysis of the research

Roberts, Natasha, Janda, Monika, Alexander, Kim and Wyld, David (2017). Patient reported outcomes (PROs) in clinical practice: a scoping review of reviews, systematic review and meta-analysis of the research. 2017 World Congress of Psycho-Oncology, 14-18 August, Berlin, Germany. Oxford, United Kingdom: John Wiley & Sons.

Patient reported outcomes (PROs) in clinical practice: a scoping review of reviews, systematic review and meta-analysis of the research

2017

Conference Publication

Outcomes comparing right and left-sided metastatic colorectal cancer: A multi-centre retrospective analysis in Queensland, Australia

Allen, Michael , Conroy, Sophie , Eastgate, Melissa , Wyld, David, Whitehall, Vicki and Burge, Matthew (2017). Outcomes comparing right and left-sided metastatic colorectal cancer: A multi-centre retrospective analysis in Queensland, Australia. Australasian Gastro-Intestinal Trials Group (AGITG) 2017 Annual Scientific Meeting, Cairns Convention Centre, Cairns, Australia, 4-6 October 2017. AGITG.

Outcomes comparing right and left-sided metastatic colorectal cancer: A multi-centre retrospective analysis in Queensland, Australia

2016

Journal Article

Factors associated with quality of care for patients with pancreatic cancer in Australia

Burmeister, Elizabeth A., O'Connell, Dianne L., Jordan, Susan J., Goldstein, David, Merrett, Neil, Wyld, David K., Beesley, Vanessa L., Gooden, Helen M., Janda, Monika and Neale, Rachel E. (2016). Factors associated with quality of care for patients with pancreatic cancer in Australia. Medical Journal of Australia, 205 (10), 459-465. doi: 10.5694/mja16.00567

Factors associated with quality of care for patients with pancreatic cancer in Australia

2016

Journal Article

Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: an Australian population-based study

Burmeister, E. A., Waterhouse, M., Jordan, S. J., O'Connell, D. L., Merrett, N. D., Goldstein, D., Wyld, D., Beesley, V., Gooden, H., Janda, M. and Neale, R. E. (2016). Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: an Australian population-based study. Pancreatology, 16 (5), 873-881. doi: 10.1016/j.pan.2016.06.010

Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: an Australian population-based study

2016

Journal Article

Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study

Beesley, Vanessa L., Wockner, Leesa F., O'Rourke, Peter, Janda, Monika, Goldstein, David, Gooden, Helen, Merrett, Neil D., O'Connell, Dianne L., Rowlands, Ingrid J., Wyld, David K. and Neale, Rachel E. (2016). Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study. Supportive Care in Cancer, 24 (8), 3589-3599. doi: 10.1007/s00520-016-3212-4

Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study

2016

Journal Article

Determinants of outcomes following resection for pancreatic cancer—a population-based study

Waterhouse, Mary A., Burmeister, Elizabeth A., O'Connell, Dianne L., Ballard, Emma L., Jordan, Susan J., Merrett, Neil D., Goldstein, David, Wyld, David, Janda, Monika, Beesley, Vanessa L., Payne, Madeleine E., Gooden, Helen M. and Neale, Rachel E. (2016). Determinants of outcomes following resection for pancreatic cancer—a population-based study. Journal of Gastrointestinal Surgery, 20 (8), 1471-1481. doi: 10.1007/s11605-016-3157-4

Determinants of outcomes following resection for pancreatic cancer—a population-based study

2016

Journal Article

Using a Delphi process to determine optimal care for patients with pancreatic cancer

Burmeister, Elizabeth A., Jordan, Susan J., O'Connell, Dianne L., Beesley, Vanessa L., Goldstein, David, Gooden, Helen M., Janda, Monika, Merrett, Neil D., Wyld, David and Neale, Rachel E. (2016). Using a Delphi process to determine optimal care for patients with pancreatic cancer. Asia-Pacific Journal of Clinical Oncology, 12 (2), 105-114. doi: 10.1111/ajco.12450

Using a Delphi process to determine optimal care for patients with pancreatic cancer

2016

Journal Article

Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (vol 24, pg 3589, 2016)

Beesley, Vanessa L., Wockner, Leesa F., O'Rourke, Peter, Janda, Monika, Goldstein, David, Gooden, Helen, Merrett, Neil D., O'Connell, Dianne L., Rowlands, Ingrid J., Wyld, David K. and Neale, Rachel E. (2016). Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (vol 24, pg 3589, 2016). Supportive Care in Cancer, 24 (8), 3601-3602. doi: 10.1007/s00520-016-3251-x

Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (vol 24, pg 3589, 2016)

2016

Conference Publication

A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET)

Ladwa, R., Burge, M. and Wyld, D. (2016). A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET). 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET)

2016

Conference Publication

A prospective 2-year experience of a medical oncology advanced trainee in Queensland

Ladwa, Rahul, Chern, Boris, Sanmugarajah, Jasotha and Wyld, David (2016). A prospective 2-year experience of a medical oncology advanced trainee in Queensland. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing.

A prospective 2-year experience of a medical oncology advanced trainee in Queensland

2016

Journal Article

RAD51B in familial breast cancer

Pelttari, Liisa M., Khan, Sofia, Vuorela, Mikko, Kiiski, Johanna I., Vilske, Sara, Nevanlinna, Viivi, Ranta, Salla, Schleutker, Johanna, Winqvist, Robert, Kallioniemi, Anne, Dörk, Thilo, Bogdanova, Natalia V., Figueroa, Jonine, Pharoah, Paul D. P., Schmidt, Marjanka K., Dunning, Alison M., García-Closas, Montserrat, Bolla, Manjeet K., Dennis, Joe, Michailidou, Kyriaki, Wang, Qin, Hopper, John L., Southey, Melissa C., Rosenberg, Efraim H., Fasching, Peter A., Beckmann, Matthias W., Peto, Julian, Dos-Santos-silva, Isabel, Sawyer, Elinor J. ... Zeps, N. (2016). RAD51B in familial breast cancer. PLoS One, 11 (5) e0153788, e0153788. doi: 10.1371/journal.pone.0153788

RAD51B in familial breast cancer

2016

Journal Article

Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer

Schofield, Penelope E., Stockler, M. R., Zannino, D., Tebbutt, N. C., Price, T. J., Simes, R. J., Wong, N., Pavlakis, N., Ransom, D., Moylan, E., Underhill, C., Wyld, D., Burns, I., Ward, R., Wilcken, N. and Jefford, M. (2016). Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer. Supportive Care in Cancer, 24 (1), 401-408. doi: 10.1007/s00520-015-2792-8

Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer

2016

Conference Publication

The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression

Ladwa, R., Lyle, M., Wyld, D. and Burge, M. (2016). The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression

2016

Conference Publication

A single center experience of cardiac metastasis from neuroendocrine tumors (net)

Ladwa, Rahul, Burge, Matthew and Wyld, David (2016). A single center experience of cardiac metastasis from neuroendocrine tumors (net). COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646

A single center experience of cardiac metastasis from neuroendocrine tumors (net)

2016

Conference Publication

How Long Is the Piece of String? - How Patients Negotiate the Uncertainties of a NET Diagnosis

Wyld, D., Plage, S., Burge, M., Broom, A., Lwin, Z., McDade, H. and Cubitt, A. (2016). How Long Is the Piece of String? - How Patients Negotiate the Uncertainties of a NET Diagnosis. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

How Long Is the Piece of String? - How Patients Negotiate the Uncertainties of a NET Diagnosis

2016

Conference Publication

Dosimetry to Estimate the Effect of Gelofusine (R) on the Renal Absorbed Dose of Lutetium 177-DOTA-Octreotate

Lucas, C., Goodman, S., Smith, J., Burge, M., Wyld, D. and Kumar, Ravi A. (2016). Dosimetry to Estimate the Effect of Gelofusine (R) on the Renal Absorbed Dose of Lutetium 177-DOTA-Octreotate. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

Dosimetry to Estimate the Effect of Gelofusine (R) on the Renal Absorbed Dose of Lutetium 177-DOTA-Octreotate

2016

Conference Publication

Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand)

Chan, B. A., Sim, H-W., Ravikumar, A., Bailey, D., Chan, D., Lawrence, B., McEwan, A., Pavlakis, N., Segelov, E., Singh, S., Roach, P. and Wyld, D. (2016). Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand). Oxford, United Kingdom: Oxford University Press.

Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand)

2016

Conference Publication

Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations

Gunawan, Ben, Button, Elise, Bates, Tracey, Nasato, Gillian and Wyld, David (2016). Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646

Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations

2016

Conference Publication

Pretherapy Identification of Patients at Risk of Receiving a High Renal Dose Undergoing Peptide Receptor Radionuclide Therapy

Goodman, S., Smith, J., Kumar, Ravi A., Wyld, D. and Burge, M. (2016). Pretherapy Identification of Patients at Risk of Receiving a High Renal Dose Undergoing Peptide Receptor Radionuclide Therapy. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

Pretherapy Identification of Patients at Risk of Receiving a High Renal Dose Undergoing Peptide Receptor Radionuclide Therapy

2016

Conference Publication

A systematic review and meta-analysis of patient reporting outcomes in clinical practice

Roberts, Natasha, Janda, Monika, Alexander, Kimberley and Wyld, David (2016). A systematic review and meta-analysis of patient reporting outcomes in clinical practice. COSA's 43rd and ANZBCTG's 38th Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, Australia, 15–17 November 2016. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12635_4

A systematic review and meta-analysis of patient reporting outcomes in clinical practice

Funding

Current funding

  • 2020 - 2026
    A new radio-imaging agent to guide targeted therapy for epithelial ovarian cancer
    NHMRC MRFF EPCDR - Ovarian Cancer Research
    Open grant

Past funding

  • 2020 - 2023
    PRoCESS: Pancreatic cancer Relatives Counselling and Education Support Service trial....(MRFF RCRDUN administered by QMIR)
    Queensland Institute of Medical Research
    Open grant

Supervision

Availability

Associate Professor David Wyld is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Examining real-world evidence for immune checkpoint inhibitor (PD-L1) treatment in advanced non small cell lung cancer (NSCLC): A population based data analysis in Queensland, Australia

    Associate Advisor

    Other advisors: Professor Jason Pole

Completed supervision

Media

Enquiries

For media enquiries about Associate Professor David Wyld's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au